Navigation Links
Pharmaceutical Medical Affairs Functions Get a Boost in Budget, Staffing
Date:4/22/2011

CHAPEL HILL, N.C., April 22, 2011 /PRNewswire/ -- The growing importance of the medical affairs function coincides with a company's need to manage rapidly changing regulatory requirements in today's biopharmaceutical industry.

This year, nearly one-third of companies anticipate an increase in medical affairs funding of more than 10 percent. However, a top challenge still on the minds of medical affairs executives is insufficient resources, including budget and headcount, for developing and maintaining an effective medical affairs group.

"Medical Affairs Resources, Structures & Trends," primary research conducted by Best Practices, LLC's, provides medical affairs executives with recent trends in budget and staffing resources, key challenges and top success factors for the function.

Download a complimentary white paper at http://www3.best-in-class.com/rr1060.htm that includes selected best practices drawn from extensive primary research with executives from 25 leading biopharmaceutical companies.

The full 40-page report contains more than 100 benchmark metrics and 20 executive narratives, providing medical affairs executives with recent trends in budget and staffing resources, key challenges and top success factors for the function.

Key topics of this primary research include:

  • Organizational structures
  • Budget allocation for medical affairs functions and outsourcing
  • Recent and anticipated changes in resource levels
  • Impact on medical affairs functions on company success
  • Key success factors and challenges for medical affairs

For more information on this study and other recent primary research studies, contact us at 919.403.0251 or at bestpractices@best-in-class.com.  

BEST PRACTICES, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for more than 17 years; our clients include 48 out of the top 50 pharmaceutical companies.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cumberland Pharmaceuticals to Announce First Quarter 2011 Financial Results on May 4, 2011
2. Valeant Pharmaceuticals Responds to Cephalon Boards Letter
3. Jazz Pharmaceuticals Announces First Quarter 2011 Results Conference Call on May 3
4. Important Drug Product Notice: Luitpold Pharmaceuticals, Inc. Announces Temporary Suspension of Distribution and Manufacture of Drug Products
5. Onyx Pharmaceuticals Announces First Quarter 2011 Financial Results Teleconference and Webcast
6. Savient Pharmaceuticals to Hold First Quarter 2011 Financial Results
7. Fleming Pharmaceuticals Now Ready to Step Up Production of Nuclear Radiation Safeguard, ThyroShield®
8. Marinus Pharmaceuticals Announces Commencement of Phase 2 Trial of Ganaxolone for the Treatment of Posttraumatic Stress Disorder
9. China Botanic Pharmaceutical Announces Plans to Switch to Renewable Bio-Fuel - Straw Pellets
10. Hanmi Pharmaceuticals to Acquire the Rights for a Promising Phase II Anti-cancer Src Kinase/Pretubulin Dual Inhibitor from Kinex Pharmaceuticals, in Selected Asian Territories
11. Merrimack Pharmaceuticals Announces that Recruitment is Open in a Phase 1 Combination Study of MM-111 with Multiple Treatment Regimens in HER2 Positive Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... , Australien, 24. Februar 2017 ... diversifiziertes Unternehmen des Gesundheitsbereiches, ist erfreut, für das ... mit dem entsprechenden Vorjahreszeitraum exzellente Ergebnisse vorlegen zu ... und Aktualisierung zum Wachstum" finden Sie hier ... Gewinn nach Steuern 2,12 Millionen USD (Dez. 2015: 1,04 Millionen USD; ...
(Date:2/24/2017)... 23, 2017  The particle counters market is ... from USD 275.9 million in 2016, at a ... report: http://www.reportlinker.com/p04718602-summary/view-report.html The growing ... R&D, and growth in manufacturing industries in emerging ... for particle counters. On the other hand, technical ...
(Date:2/23/2017)... -- Research and Markets has announced the addition of ... 2016" report to their offering. ... The latest research Autism Spectrum Disorder Drugs ... benchmarks in the global Autism Spectrum Disorder market. The research ... the key drugs marketed for Autism Spectrum Disorder and their clinical ...
Breaking Medicine Technology:
(Date:2/23/2017)... , ... February 23, 2017 , ... ... approved content provider for the National Institute for Health and Care Excellence ... care-related organizations in the National Health Service (NHS) to search, order and purchase ...
(Date:2/23/2017)... ... 2017 , ... Dr. David Mahon leads Siena Dental, a comprehensive dental practice ... a 2017 Top Patient Rated Henderson Dentist by Find Local Doctors earlier ... physicians and dentists who have earned high ratings and superior patient reviews from multiple ...
(Date:2/23/2017)... ... , ... ERT, a global data and technology company that ... leading clinical development service provider, has selected ERT’s Trial Oversight suite as its ... to an array of circumstances including the use of multiple data capture modalities ...
(Date:2/23/2017)... ... 2017 , ... Healthcare Research & Analytics® (HRA®) in cooperation ... cancer, has produced a seminal study that asked cancer survivors and their caregivers ... a webinar, Defining Compassionate Care Through the Voices of Patients and Advocates that ...
(Date:2/23/2017)... Vienna, VA – , ... ... is coming. It’s the perfect opportunity for the nation to ... out a college basketball bracket – with its favorite fruit ... Association is encouraging apple lovers to join the “Apple Madness” ...
Breaking Medicine News(10 mins):